|
|
||||||||
Original Research Communications |
1 From the Department of Food Science, Swedish University of Agricultural Sciences, Uppsala; the Department of Medical Epidemiology, Karolinska Institute, Stockholm; and the Department of Geriatrics, University of Uppsala, Sweden.
| ABSTRACT |
|---|
|
|
|---|
Objective: In this study, the relation between bovine milk fat intake and the occurrence of CLA in human adipose tissue was investigated.
Design: One hundred twenty-three men weighed and recorded the foods they consumed for 1 wk. Afterward, recall interviews were conducted by telephone monthly for 7 consecutive months to inquire about food consumption during the previous 24 h. The entire dietary recording procedure was repeated once. The fatty acid composition of adipose tissue and serum was analyzed.
Results: The average amount of one isomer of CLA9-cis,11-trans-octadecadienoic acid (9c,11t-18:2)as a percentage of total fatty acids was found to be 0.50% in adipose tissue and 0.25% in serum. The amount of 9c,11t-18:2 in adipose tissue was significantly correlated with milk fat intake (r = 0.42). The percentage of 9c,11t-18:2 in both adipose tissue and in serum was strongly correlated with myristoleic acid (14:1).
Conclusion: The amount of 9c,11t-18:2 in human adipose tissue was significantly related to milk fat intake.
Key Words: Conjugated linoleic acid humans adipose tissue fatty acids milk fat intake men Sweden 9-cis 11-trans-octadecadienoic acid 9c 11t-18:2
| INTRODUCTION |
|---|
|
|
|---|
CLA is a group of naturally occurring fatty acids, mainly present in foods from ruminant sources. CLA is produced from polyunsaturated fatty acids (PUFAs) by rumen bacteria during biohydrogenation (10). Dairy products are the major dietary sources of CLA, of which 9c,11t-18:2 is the major isomer, representing 8090% of total CLA in bovine milk (11, 12).
CLA has also been identified in human serum and in bile and duodenal juices (1315). The effect of diet on plasma and serum CLA concentrations has been studied by supplying human subjects with a high-CLA diet. In 2 such studies, it was found that such a dietary modification increased plasma and serum concentrations of CLA (16, 17). However, little is known about the amount of CLA in human adipose tissue and whether this reflects dietary CLA intake. The purpose of this study was to determine the amount of CLA in adipose tissue and serum of humans and the relation between CLA concentrations and milk fat intake.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Dietary assessment
Before completing the self-administered dietary records, each participant obtained detailed instructions from a research dietitian about how to weigh and record all foods consumed. During telephone interviews, a standardized form for the 24-h dietary recall was used to collect the data. Dietary data from food records and telephone interviews were computerized by using the personal computer program MATS (18), which includes a listing of 1593 foods and dishes. Nutrients were calculated by using the Swedish Food Administration Food Database (19). This database provides information on the contents of 14 main fatty acids in different foods. Milk fat intake was estimated by summing the amounts of total fat from all dairy products and the milk fat from dishes containing dairy ingredients. Total energy and nutrient intakes for each subject were calculated as the mean daily intake derived from both the dietary records and 24-h recall interviews. The daily intake of CLA was estimated according to published data on the concentration of CLA in total fat in different foods (11, 20).
Blood sampling and adipose tissue biopsy
Blood samples were drawn from an antecubital vein under standardized conditions after a 12-h overnight fast. After the blood was coagulated for 2 h at room temperature, serum was separated by low-speed centrifugation (2000 x g for 10 min at 20°C) and stored at 4°C until analyzed for serum lipids, which was done within 24 h. Triacylglycerol and cholesterol concentrations were measured in serum enzymatically by using the IL Test Triacylglycerol Enzymatic-Colorimetric Method 181709-00 and IL Test Cholesterol Triander's method 181618-80, respectively, with a Monarch apparatus (Instrumentation Laboratory, Lexington, MA). Biopsies from subcutaneous adipose tissue were obtained by fine-needle biopsy of the upper-outer quadrant of the buttock as described by Beynen and Katan (21). The tissue samples were stored at -70°C until analyzed.
Lipid extraction and analyses
Aspirated adipose tissue samples weighing 2040 mg were homogenized and extracted with 15 mL chloroform:methanol (2:1, by vol) according to the method of Folch et al (22). For fatty acid analysis, 4 mL of the chloroform phase was dehydrated with anhydrous sodium sulfate and the solution was transferred into a screw-capped test tube. After the solvent was evaporated, the residue was dissolved in 1 mL chloroform. The total amounts of lipid were then quantified with a microbalance (Mettler MT/UMT; Mettler-Toledo AG, Grifensee, Switzerland).
The methyl esters of the extracted lipid were prepared by adding 2 mL 0.01 mol NaOH/L in dry methanol and heating in a continuously shaken glycerol bath for 15 min at 60°C. Afterward, 3 mL BF3 in methanol (20%) was added and the mixtures were heated for 15 min at 60°C. The test tube was then removed from the glycerol bath and cooled under cold, running water. After 2 mL 20% NaCl and 1 mL hexane were added, the mixture was mixed vigorously and centrifuged at 2500 x g for 5 min at 20°C. The hexane phase was collected and the fatty acid methyl esters were redissolved in 400 µL hexane for gas chromatographic quantification.
The methyl esters of CLA were analyzed with an HP5890 series II gas chromatograph (Hewlett-Packard Co, Rolling Meadows, IL) fitted with a flame ionization detector. The chromatogram was integrated by using computer software (JCL6000; Jones Chromatography Ltd, Mid Glam, United Kingdom). Samples were injected through the split injection port (split ratio, 40:1) onto a CP Sil 88 fused silica capillary column (50 m x 0.22 mm, 0.2-mm file thickness; Chrompack, Middelburg, Netherlands). The nitrogen carrier gas flow was 2 mL/min and the injector and detector temperatures were 250°C. The oven temperature was programmed at 120°C for 3 min, increased from 120 to 180°C at a rate of 5°C/min, and then held at 180°C for 25 min. Individual fatty acids were identified by comparing relative retention times with individual fatty acid standards (Larodan Fine Chemical AB, Malmö, Sweden). Heneicosanoic acid methyl ester (Larodan Fine Chemical AB) was used as an internal standard for quantification. Analytic results for CLA and other fatty acids were expressed as percentages of total fatty acids. Lipid from the corresponding serum samples (n = 123) was extracted, methylated, and analyzed by gas chromatography by using the same methods used for adipose tissue analysis.
Data analysis
Spearman correlation was used to analyze the relations between dietary intake and the amounts of specific fatty acids in adipose tissue and serum. Significant relations between fatty acids were plotted by using linear regression analysis. The analyses were performed by using the SAS statistical package (23).
| RESULTS |
|---|
|
|
|---|
The average daily intake of selected nutrients is shown in Table 1
. Mean intakes of total energy and nutrients were not significantly different between the 2 dietary recording methods. The average daily milk fat intake estimated in this study group was
25 g. The intakes of 10 major fatty acids were also estimated; palmitic acid (16:0), stearic acid (18:0), cis-oleic acid (c-18:1), and 18:2 accounted for >80% of the total fat intake. The estimated intake of CLA was
160 mg/d, which included CLA from both milk fat and the fat of ruminant meat products (11, 20).
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The effect of the consumption of dairy products on plasma CLA concentrations in humans was studied by supplementing the diet of men with cheddar cheese, which resulted in a 1927% increase in the plasma CLA concentration (16). This finding indicated that dietary modification can increase the CLA concentration in human plasma. It is known that dietary intake is also an important factor that can influence the fatty acid composition of human adipose tissue (29, 30). In the present study, the correlation between the fatty acid profile of adipose tissue and dietary milk fat intake determined by 2 different dietary assessment methods showed similar results, ie, the amount of 9c,11t-18:2 in adipose tissue was significantly correlated with milk fat intake.
In addition to the dietary factor, the endogenous formation of 9c,11t-18:2 was shown in rats by means of desaturation of 11-octadecanoic acid by liver microsomes (31) and by conversion of free 18:2 to CLA by the intestinal flora (32). Similar processes may occur in humans; eg, it was shown that dietary trans fatty acids increase CLA concentrations in human serum, which suggests that CLA in human tissues is partly derived from the diet, but that part of it may be formed via the conversion of dietary trans fatty acids (33). An elevated concentration of CLA in the cervix was observed as a result of bacterial colonization and activity (34). However, a recent study of the possible isomerization of 18:2 to CLA by human intestinal microflora reported that the supplementation of safflower oil with triacylglycerol-esterified 18:2 did not increase plasma concentrations of esterified CLA in total lipids (35).
The incorporation of dietary CLA into various tissues was studied and was found to be tissue dependent, eg, adipose tissue and lung tissue contain the most and brain tissue the least (36). In the present study, it was found that the average amount of CLA in human adipose tissue was twice as high as in serum, and there was no significant correlation between the amount of CLA in adipose tissue and in serum. These results warrant further studies of the incorporation of dietary CLA into human adipose tissue and the turnover rate, endogenous formation, and metabolism of CLA in humans.
Regarding the relations between different fatty acids in adipose tissue, no positive correlation was found between 9c,11t-18:2 and 18:2, which agrees with the results reported for human plasma (16). Jiang et al (37) showed previously a strong correlation between 9c,11t-18:2 and trans-vaccenic acid (11t-18:1) in bovine milk (r = 0.78). However, a weaker correlation (r = 0.20) was observed between 9c,11t-18:2 and total t-18:1 in human adipose tissue in this study. The result that 9c,11t-18:2 was significantly correlated with 15:0 might substantiate the observed correlation between 9c,11t-18:2 and milk fat intake because 15:0 has been shown to be a good biological marker of milk fat intake in human adipose tissue (38). Of interest are the strong correlations between 9c,11t-18:2 and 14:1 and of 9c,11t-18:2 and 16:1 in adipose tissue. The reason for these relations is not understood and thus requires further investigation. The data published in 1964 (24) showed that the amounts of 14:1 and 16:1 in adipose tissue in men were twice as high in the 1960s as in the more recent investigations. This may indicate a higher concentration of CLA in human adipose tissue in the 1960s, as judged from the strong correlations between CLA and 14:1 and 16:1 found in the present study. This observation is consistent with the reduced consumption of total animal fat (eg, butter, full-fat milk, and fat from ruminant meats) in recent decades, although the reason for these differences may be due in part to divergent fat intakes in different countries.
In conclusion, milk fat has been shown to be associated with negative health effects because of its high SFA content. The increased knowledge about the positive health effects associated with CLA, the occurrence of CLA in milk, and the transfer of CLA from milk fat in the diet to human adipose tissue, as shown in this investigation, may warrant reevaluation of the health aspects of milk fat. However, before such a reevaluation can be made, additional scientific data on the nutritional effects of CLA are required.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Address reprint requests to J Jiang, Department of Food Science, Swedish University of Agricultural Sciences, PO Box 7051, S-750 07 Uppsala, Sweden. E-mail: Jin.Jiang{at}lmv.slu.se.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Raff, T. Tholstrup, S. Basu, P. Nonboe, M. T. Sorensen, and E. M. Straarup A Diet Rich in Conjugated Linoleic Acid and Butter Increases Lipid Peroxidation but Does Not Affect Atherosclerotic, Inflammatory, or Diabetic Risk Markers in Healthy Young Men J. Nutr., March 1, 2008; 138(3): 509 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Suksombat, T. Boonmee, and P. Lounglawan Effects of Various Levels of Conjugated Linoleic Acid Supplementation on Fatty Acid Content and Carcass Composition of Broilers Poult. Sci., February 1, 2007; 86(2): 318 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Badinga and E. S. Greene Physiological Properties of Conjugated Linoleic Acid and Implications for Human Health Nutr Clin Pract, August 1, 2006; 21(4): 367 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raff, T. Tholstrup, K. Sejrsen, E. M. Straarup, and N. Wiinberg Diets Rich in Conjugated Linoleic Acid and Vaccenic Acid Have No Effect on Blood Pressure and Isobaric Arterial Elasticity in Healthy Young Men J. Nutr., April 1, 2006; 136(4): 992 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Larsen, S. Toubro, O. Gudmundsen, and A. Astrup Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain Am. J. Clinical Nutrition, March 1, 2006; 83(3): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moloney, T.-P. Yeow, A. Mullen, J. J Nolan, and H. M Roche Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus Am. J. Clinical Nutrition, October 1, 2004; 80(4): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Palmquist, N. St-Pierre, and K. E. McClure Tissue Fatty Acid Profiles Can Be Used to Quantify Endogenous Rumenic Acid Synthesis in Lambs J. Nutr., September 1, 2004; 134(9): 2407 - 2414. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Adolfsson, S. N. Meydani, and R. M Russell Yogurt and gut function Am. J. Clinical Nutrition, August 1, 2004; 80(2): 245 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Larsen, S. Toubro, and A. Astrup Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies J. Lipid Res., December 1, 2003; 44(12): 2234 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eder, S. Schleser, K. Becker, and R. Korting Conjugated Linoleic Acids Lower the Release of Eicosanoids and Nitric Oxide from Human Aortic Endothelial Cells J. Nutr., December 1, 2003; 133(12): 4083 - 4089. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E Voorrips, H. A. Brants, A. F. Kardinaal, G. J Hiddink, P. A van den Brandt, and R A. Goldbohm Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer Am. J. Clinical Nutrition, October 1, 2002; 76(4): 873 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Turpeinen, M. Mutanen, A. Aro, I. Salminen, S. Basu, D. L Palmquist, and J M. Griinari Bioconversion of vaccenic acid to conjugated linoleic acid in humans Am. J. Clinical Nutrition, September 1, 2002; 76(3): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.W. Ryder, C.P. Portocarrero, X.M. Song, L. Cui, M. Yu, T. Combatsiaris, D. Galuska, D.E. Bauman, D.M. Barbano, M.J. Charron, et al. Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid: Improved Glucose Tolerance, Skeletal Muscle Insulin Action, and UCP-2 Gene Expression Diabetes, May 1, 2001; 50(5): 1149 - 1157. [Abstract] [Full Text] |
||||
![]() |
K. L. Ritzenthaler, M. K. McGuire, R. Falen, T. D. Shultz, N. Dasgupta, and M. A. McGuire Estimation of Conjugated Linoleic Acid Intake by Written Dietary Assessment Methodologies Underestimates Actual Intake Evaluated by Food Duplicate Methodology J. Nutr., May 1, 2001; 131(5): 1548 - 1554. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |